Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months&apos; follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Intracoronary transfer of autologous bone marrow cells (BMCs) may enhance recovery of left ventricular (LV) function in patients after acute myocardial infarction (AMI). However, clinical studies addressing the effects of BMCs after AMI have covered only limited time frames ranging from 3 to 6 months. The critical question of whether BMC transfer can have a sustained impact on LV function remains unanswered.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Circulation

Title: Circulation

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1524-4539

ISSN (Print): 0009-7322

Publication date (Electronic): Mar 14 2006

Volume: 113

Issue: 10

Affiliations

[1 ] Department of Cardiology, Hannover Medical School, Hannover, Germany.

Article

Publisher Item ID: CIRCULATIONAHA.105.575118

DOI: 10.1161/CIRCULATIONAHA.105.575118

PubMed ID: 16520413

SO-VID: f5739500-c4eb-4f17-8c64-6ecd8d73ef35

History

Data availability:

Comments

Comment on this article

scite_

Cited by 124

See all cited by

- Version 1

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Read this article at